Investor Relations

Azenta is dedicated to enabling life sciences organizations around the world to bring impactful breakthroughs and therapies to market – faster.

Press Releases

Jul 08, 2026

Azenta, Inc. (Nasdaq: AZTA) today announced the completion of the previously disclosed sale of its B Medical Systems business to Thelema S.à r.l. The transaction was originally announced on...

May 21, 2026

Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, demonstrating continued progress against its key ESG priorities. The...

May 05, 2026

FY'26 total reported revenue from continuing operations to range between approximately $603 to $621 million FY'26 organic revenue is now expected to range from down approximately 2% to up 1%,...

View all news

Loading data...